0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pirfenidone Tablets Market Research Report 2024
Published Date: August 2024
|
Report Code: QYRE-Auto-32Y17915
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Pirfenidone Tablets Market Research Report 2024
BUY CHAPTERS

Global Pirfenidone Tablets Market Research Report 2024

Code: QYRE-Auto-32Y17915
Report
August 2024
Pages:81
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Pirfenidone Tablets Market

Pirfenidone tablets are a medication used to treat idiopathic pulmonary fibrosis(IPF),a progressive lung disease characterized by the formation of scar tissue in the lungs.It inhibits the synthesis of pro-inflammatory cytokines and growth factors like transforming growth factor-beta(TGF-β),which helps slow the progression of IPF,preserving lung function and potentially improving quality of life for patients.
The global Pirfenidone Tablets market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Pirfenidone Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Pirfenidone Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Pirfenidone Tablets include Roche, Accord Healthcare, Amneal Pharmaceuticals, Apotex, Sandoz, Teva, ScieGen Pharmaceuticals, Kawin, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pirfenidone Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pirfenidone Tablets.
The Pirfenidone Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Pirfenidone Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pirfenidone Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Pirfenidone Tablets Market Report

Report Metric Details
Report Name Pirfenidone Tablets Market
Segment by Type
  • 200mg per Tablet
  • 267mg per Tablet
  • 801mg per Tablet
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Roche, Accord Healthcare, Amneal Pharmaceuticals, Apotex, Sandoz, Teva, ScieGen Pharmaceuticals, Kawin
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Pirfenidone Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Pirfenidone Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Pirfenidone Tablets Market report?

Ans: The main players in the Pirfenidone Tablets Market are Roche, Accord Healthcare, Amneal Pharmaceuticals, Apotex, Sandoz, Teva, ScieGen Pharmaceuticals, Kawin

What are the Application segmentation covered in the Pirfenidone Tablets Market report?

Ans: The Applications covered in the Pirfenidone Tablets Market report are Hospital and Clinic, Retail Pharmacies, Other

What are the Type segmentation covered in the Pirfenidone Tablets Market report?

Ans: The Types covered in the Pirfenidone Tablets Market report are 200mg per Tablet, 267mg per Tablet, 801mg per Tablet

Recommended Reports

Respiratory Diseases

Fibrosis & Fibrotic Therapy

Tablets & APIs

1 Pirfenidone Tablets Market Overview
1.1 Product Definition
1.2 Pirfenidone Tablets by Type
1.2.1 Global Pirfenidone Tablets Market Value Comparison by Type (2024-2030)
1.2.2 200mg per Tablet
1.2.3 267mg per Tablet
1.2.4 801mg per Tablet
1.3 Pirfenidone Tablets by Application
1.3.1 Global Pirfenidone Tablets Market Value by Application (2024-2030)
1.3.2 Hospital and Clinic
1.3.3 Retail Pharmacies
1.3.4 Other
1.4 Global Pirfenidone Tablets Market Size Estimates and Forecasts
1.4.1 Global Pirfenidone Tablets Revenue 2019-2030
1.4.2 Global Pirfenidone Tablets Sales 2019-2030
1.4.3 Global Pirfenidone Tablets Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Pirfenidone Tablets Market Competition by Manufacturers
2.1 Global Pirfenidone Tablets Sales Market Share by Manufacturers (2019-2024)
2.2 Global Pirfenidone Tablets Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Pirfenidone Tablets Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Pirfenidone Tablets, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pirfenidone Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pirfenidone Tablets, Product Type & Application
2.7 Global Key Manufacturers of Pirfenidone Tablets, Date of Enter into This Industry
2.8 Global Pirfenidone Tablets Market Competitive Situation and Trends
2.8.1 Global Pirfenidone Tablets Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Pirfenidone Tablets Players Market Share by Revenue
2.8.3 Global Pirfenidone Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pirfenidone Tablets Market Scenario by Region
3.1 Global Pirfenidone Tablets Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Pirfenidone Tablets Sales by Region: 2019-2030
3.2.1 Global Pirfenidone Tablets Sales by Region: 2019-2024
3.2.2 Global Pirfenidone Tablets Sales by Region: 2025-2030
3.3 Global Pirfenidone Tablets Revenue by Region: 2019-2030
3.3.1 Global Pirfenidone Tablets Revenue by Region: 2019-2024
3.3.2 Global Pirfenidone Tablets Revenue by Region: 2025-2030
3.4 North America Pirfenidone Tablets Market Facts & Figures by Country
3.4.1 North America Pirfenidone Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Pirfenidone Tablets Sales by Country (2019-2030)
3.4.3 North America Pirfenidone Tablets Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pirfenidone Tablets Market Facts & Figures by Country
3.5.1 Europe Pirfenidone Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Pirfenidone Tablets Sales by Country (2019-2030)
3.5.3 Europe Pirfenidone Tablets Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pirfenidone Tablets Market Facts & Figures by Region
3.6.1 Asia Pacific Pirfenidone Tablets Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Pirfenidone Tablets Sales by Region (2019-2030)
3.6.3 Asia Pacific Pirfenidone Tablets Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pirfenidone Tablets Market Facts & Figures by Country
3.7.1 Latin America Pirfenidone Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Pirfenidone Tablets Sales by Country (2019-2030)
3.7.3 Latin America Pirfenidone Tablets Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Pirfenidone Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Pirfenidone Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Pirfenidone Tablets Sales by Country (2019-2030)
3.8.3 Middle East and Africa Pirfenidone Tablets Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pirfenidone Tablets Sales by Type (2019-2030)
4.1.1 Global Pirfenidone Tablets Sales by Type (2019-2024)
4.1.2 Global Pirfenidone Tablets Sales by Type (2025-2030)
4.1.3 Global Pirfenidone Tablets Sales Market Share by Type (2019-2030)
4.2 Global Pirfenidone Tablets Revenue by Type (2019-2030)
4.2.1 Global Pirfenidone Tablets Revenue by Type (2019-2024)
4.2.2 Global Pirfenidone Tablets Revenue by Type (2025-2030)
4.2.3 Global Pirfenidone Tablets Revenue Market Share by Type (2019-2030)
4.3 Global Pirfenidone Tablets Price by Type (2019-2030)
5 Segment by Application
5.1 Global Pirfenidone Tablets Sales by Application (2019-2030)
5.1.1 Global Pirfenidone Tablets Sales by Application (2019-2024)
5.1.2 Global Pirfenidone Tablets Sales by Application (2025-2030)
5.1.3 Global Pirfenidone Tablets Sales Market Share by Application (2019-2030)
5.2 Global Pirfenidone Tablets Revenue by Application (2019-2030)
5.2.1 Global Pirfenidone Tablets Revenue by Application (2019-2024)
5.2.2 Global Pirfenidone Tablets Revenue by Application (2025-2030)
5.2.3 Global Pirfenidone Tablets Revenue Market Share by Application (2019-2030)
5.3 Global Pirfenidone Tablets Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Company Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Pirfenidone Tablets Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Roche Pirfenidone Tablets Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Accord Healthcare
6.2.1 Accord Healthcare Company Information
6.2.2 Accord Healthcare Description and Business Overview
6.2.3 Accord Healthcare Pirfenidone Tablets Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Accord Healthcare Pirfenidone Tablets Product Portfolio
6.2.5 Accord Healthcare Recent Developments/Updates
6.3 Amneal Pharmaceuticals
6.3.1 Amneal Pharmaceuticals Company Information
6.3.2 Amneal Pharmaceuticals Description and Business Overview
6.3.3 Amneal Pharmaceuticals Pirfenidone Tablets Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Amneal Pharmaceuticals Pirfenidone Tablets Product Portfolio
6.3.5 Amneal Pharmaceuticals Recent Developments/Updates
6.4 Apotex
6.4.1 Apotex Company Information
6.4.2 Apotex Description and Business Overview
6.4.3 Apotex Pirfenidone Tablets Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Apotex Pirfenidone Tablets Product Portfolio
6.4.5 Apotex Recent Developments/Updates
6.5 Sandoz
6.5.1 Sandoz Company Information
6.5.2 Sandoz Description and Business Overview
6.5.3 Sandoz Pirfenidone Tablets Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sandoz Pirfenidone Tablets Product Portfolio
6.5.5 Sandoz Recent Developments/Updates
6.6 Teva
6.6.1 Teva Company Information
6.6.2 Teva Description and Business Overview
6.6.3 Teva Pirfenidone Tablets Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Teva Pirfenidone Tablets Product Portfolio
6.6.5 Teva Recent Developments/Updates
6.7 ScieGen Pharmaceuticals
6.7.1 ScieGen Pharmaceuticals Company Information
6.7.2 ScieGen Pharmaceuticals Description and Business Overview
6.7.3 ScieGen Pharmaceuticals Pirfenidone Tablets Sales, Revenue and Gross Margin (2019-2024)
6.7.4 ScieGen Pharmaceuticals Pirfenidone Tablets Product Portfolio
6.7.5 ScieGen Pharmaceuticals Recent Developments/Updates
6.8 Kawin
6.8.1 Kawin Company Information
6.8.2 Kawin Description and Business Overview
6.8.3 Kawin Pirfenidone Tablets Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Kawin Pirfenidone Tablets Product Portfolio
6.8.5 Kawin Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pirfenidone Tablets Industry Chain Analysis
7.2 Pirfenidone Tablets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pirfenidone Tablets Production Mode & Process
7.4 Pirfenidone Tablets Sales and Marketing
7.4.1 Pirfenidone Tablets Sales Channels
7.4.2 Pirfenidone Tablets Distributors
7.5 Pirfenidone Tablets Customers
8 Pirfenidone Tablets Market Dynamics
8.1 Pirfenidone Tablets Industry Trends
8.2 Pirfenidone Tablets Market Drivers
8.3 Pirfenidone Tablets Market Challenges
8.4 Pirfenidone Tablets Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Pirfenidone Tablets Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Pirfenidone Tablets Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Pirfenidone Tablets Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Pirfenidone Tablets Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Pirfenidone Tablets Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Pirfenidone Tablets Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Pirfenidone Tablets Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Pirfenidone Tablets Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Pirfenidone Tablets, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Pirfenidone Tablets, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Pirfenidone Tablets, Product Type & Application
 Table 12. Global Key Manufacturers of Pirfenidone Tablets, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Pirfenidone Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pirfenidone Tablets as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Pirfenidone Tablets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Pirfenidone Tablets Sales by Region (2019-2024) & (K Units)
 Table 18. Global Pirfenidone Tablets Sales Market Share by Region (2019-2024)
 Table 19. Global Pirfenidone Tablets Sales by Region (2025-2030) & (K Units)
 Table 20. Global Pirfenidone Tablets Sales Market Share by Region (2025-2030)
 Table 21. Global Pirfenidone Tablets Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Pirfenidone Tablets Revenue Market Share by Region (2019-2024)
 Table 23. Global Pirfenidone Tablets Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Pirfenidone Tablets Revenue Market Share by Region (2025-2030)
 Table 25. North America Pirfenidone Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Pirfenidone Tablets Sales by Country (2019-2024) & (K Units)
 Table 27. North America Pirfenidone Tablets Sales by Country (2025-2030) & (K Units)
 Table 28. North America Pirfenidone Tablets Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Pirfenidone Tablets Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Pirfenidone Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Pirfenidone Tablets Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Pirfenidone Tablets Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Pirfenidone Tablets Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Pirfenidone Tablets Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Pirfenidone Tablets Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Pirfenidone Tablets Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Pirfenidone Tablets Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Pirfenidone Tablets Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Pirfenidone Tablets Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Pirfenidone Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Pirfenidone Tablets Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Pirfenidone Tablets Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Pirfenidone Tablets Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Pirfenidone Tablets Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Pirfenidone Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Pirfenidone Tablets Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Pirfenidone Tablets Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Pirfenidone Tablets Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Pirfenidone Tablets Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Pirfenidone Tablets Sales (K Units) by Type (2019-2024)
 Table 51. Global Pirfenidone Tablets Sales (K Units) by Type (2025-2030)
 Table 52. Global Pirfenidone Tablets Sales Market Share by Type (2019-2024)
 Table 53. Global Pirfenidone Tablets Sales Market Share by Type (2025-2030)
 Table 54. Global Pirfenidone Tablets Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Pirfenidone Tablets Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Pirfenidone Tablets Revenue Market Share by Type (2019-2024)
 Table 57. Global Pirfenidone Tablets Revenue Market Share by Type (2025-2030)
 Table 58. Global Pirfenidone Tablets Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Pirfenidone Tablets Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Pirfenidone Tablets Sales (K Units) by Application (2019-2024)
 Table 61. Global Pirfenidone Tablets Sales (K Units) by Application (2025-2030)
 Table 62. Global Pirfenidone Tablets Sales Market Share by Application (2019-2024)
 Table 63. Global Pirfenidone Tablets Sales Market Share by Application (2025-2030)
 Table 64. Global Pirfenidone Tablets Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Pirfenidone Tablets Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Pirfenidone Tablets Revenue Market Share by Application (2019-2024)
 Table 67. Global Pirfenidone Tablets Revenue Market Share by Application (2025-2030)
 Table 68. Global Pirfenidone Tablets Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Pirfenidone Tablets Price (US$/Unit) by Application (2025-2030)
 Table 70. Roche Company Information
 Table 71. Roche Description and Business Overview
 Table 72. Roche Pirfenidone Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Roche Pirfenidone Tablets Product
 Table 74. Roche Recent Developments/Updates
 Table 75. Accord Healthcare Company Information
 Table 76. Accord Healthcare Description and Business Overview
 Table 77. Accord Healthcare Pirfenidone Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Accord Healthcare Pirfenidone Tablets Product
 Table 79. Accord Healthcare Recent Developments/Updates
 Table 80. Amneal Pharmaceuticals Company Information
 Table 81. Amneal Pharmaceuticals Description and Business Overview
 Table 82. Amneal Pharmaceuticals Pirfenidone Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Amneal Pharmaceuticals Pirfenidone Tablets Product
 Table 84. Amneal Pharmaceuticals Recent Developments/Updates
 Table 85. Apotex Company Information
 Table 86. Apotex Description and Business Overview
 Table 87. Apotex Pirfenidone Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Apotex Pirfenidone Tablets Product
 Table 89. Apotex Recent Developments/Updates
 Table 90. Sandoz Company Information
 Table 91. Sandoz Description and Business Overview
 Table 92. Sandoz Pirfenidone Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Sandoz Pirfenidone Tablets Product
 Table 94. Sandoz Recent Developments/Updates
 Table 95. Teva Company Information
 Table 96. Teva Description and Business Overview
 Table 97. Teva Pirfenidone Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. Teva Pirfenidone Tablets Product
 Table 99. Teva Recent Developments/Updates
 Table 100. ScieGen Pharmaceuticals Company Information
 Table 101. ScieGen Pharmaceuticals Description and Business Overview
 Table 102. ScieGen Pharmaceuticals Pirfenidone Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. ScieGen Pharmaceuticals Pirfenidone Tablets Product
 Table 104. ScieGen Pharmaceuticals Recent Developments/Updates
 Table 105. Kawin Company Information
 Table 106. Kawin Description and Business Overview
 Table 107. Kawin Pirfenidone Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. Kawin Pirfenidone Tablets Product
 Table 109. Kawin Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Pirfenidone Tablets Distributors List
 Table 113. Pirfenidone Tablets Customers List
 Table 114. Pirfenidone Tablets Market Trends
 Table 115. Pirfenidone Tablets Market Drivers
 Table 116. Pirfenidone Tablets Market Challenges
 Table 117. Pirfenidone Tablets Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Pirfenidone Tablets
 Figure 2. Global Pirfenidone Tablets Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Pirfenidone Tablets Market Share by Type: 2023 & 2030
 Figure 4. 200mg per Tablet Product Picture
 Figure 5. 267mg per Tablet Product Picture
 Figure 6. 801mg per Tablet Product Picture
 Figure 7. Global Pirfenidone Tablets Market Value by Application (2024-2030) & (US$ Million)
 Figure 8. Global Pirfenidone Tablets Market Share by Application: 2023 & 2030
 Figure 9. Hospital and Clinic
 Figure 10. Retail Pharmacies
 Figure 11. Other
 Figure 12. Global Pirfenidone Tablets Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 13. Global Pirfenidone Tablets Market Size (2019-2030) & (US$ Million)
 Figure 14. Global Pirfenidone Tablets Sales (2019-2030) & (K Units)
 Figure 15. Global Pirfenidone Tablets Average Price (US$/Unit) & (2019-2030)
 Figure 16. Pirfenidone Tablets Report Years Considered
 Figure 17. Pirfenidone Tablets Sales Share by Manufacturers in 2023
 Figure 18. Global Pirfenidone Tablets Revenue Share by Manufacturers in 2023
 Figure 19. Global 5 and 10 Largest Pirfenidone Tablets Players: Market Share by Revenue in Pirfenidone Tablets in 2023
 Figure 20. Pirfenidone Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 21. Global Pirfenidone Tablets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 22. North America Pirfenidone Tablets Sales Market Share by Country (2019-2030)
 Figure 23. North America Pirfenidone Tablets Revenue Market Share by Country (2019-2030)
 Figure 24. United States Pirfenidone Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Canada Pirfenidone Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 26. Europe Pirfenidone Tablets Sales Market Share by Country (2019-2030)
 Figure 27. Europe Pirfenidone Tablets Revenue Market Share by Country (2019-2030)
 Figure 28. Germany Pirfenidone Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. France Pirfenidone Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. U.K. Pirfenidone Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Italy Pirfenidone Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Russia Pirfenidone Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Asia Pacific Pirfenidone Tablets Sales Market Share by Region (2019-2030)
 Figure 34. Asia Pacific Pirfenidone Tablets Revenue Market Share by Region (2019-2030)
 Figure 35. China Pirfenidone Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. Japan Pirfenidone Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. South Korea Pirfenidone Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. India Pirfenidone Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. Australia Pirfenidone Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. China Taiwan Pirfenidone Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Southeast Asia Pirfenidone Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Latin America Pirfenidone Tablets Sales Market Share by Country (2019-2030)
 Figure 43. Mexico Pirfenidone Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Brazil Pirfenidone Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Argentina Pirfenidone Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Colombia Pirfenidone Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Middle East and Africa Pirfenidone Tablets Sales Market Share by Country (2019-2030)
 Figure 48. Middle East and Africa Pirfenidone Tablets Revenue Market Share by Country (2019-2030)
 Figure 49. Turkey Pirfenidone Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Saudi Arabia Pirfenidone Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. UAE Pirfenidone Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Global Sales Market Share of Pirfenidone Tablets by Type (2019-2030)
 Figure 53. Global Revenue Market Share of Pirfenidone Tablets by Type (2019-2030)
 Figure 54. Global Pirfenidone Tablets Price (US$/Unit) by Type (2019-2030)
 Figure 55. Global Sales Market Share of Pirfenidone Tablets by Application (2019-2030)
 Figure 56. Global Revenue Market Share of Pirfenidone Tablets by Application (2019-2030)
 Figure 57. Global Pirfenidone Tablets Price (US$/Unit) by Application (2019-2030)
 Figure 58. Pirfenidone Tablets Value Chain
 Figure 59. Pirfenidone Tablets Production Process
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc